Drug quality audits in China address cross-contamination by implementing stringent Good Manufacturing Practices (GMP) standards, conducting regular inspections, and enforcing strict segregation protocols. They ensure proper cleaning procedures, validate equipment, and train personnel to prevent contamination. Regulatory bodies like the National Medical Products Administration (NMPA) oversee compliance to maintain drug safety.